REAGENTSLIN-C LINEARITY CONTROLS CONSIST OF TREATED, STABILIZED HUMAN ERYTHROCYTES IN AN ISOTONIC, BACTERIOSTATIC MEDIUM. LINEARITY CONTROLS ALSO CONTAIN A STABILIZED PLATELET-SIZED COMPONENT, AND FIXED ERYTHROCYTES TO SIMULATE LEUKOCYTES.

共有 1 個藥物證書使用此成份

貝克曼庫爾特 庫爾特線性品管劑
BECKMAN COULTER LIN-C LINEARITY CONTROL

申請商
美商貝克曼庫爾特有限公司台灣分公司 
適應症
含量
發證日期
2005-09-02